Literature DB >> 12409317

Prevention of spontaneous mammary adenocarcinoma in HER-2/neu transgenic mice by foreign DNA.

Lucia Sfondrini1, Dario Besusso, Cristiano Rumio, Monica Rodolfo, Sylvie Ménard, Andrea Balsari.   

Abstract

Unmethylated CpG-oligodeoxynucleotides (CpG-ODNs) are recognized as a 'danger signal' and are potent immunostimulators. To test whether tumors might be prevented by maintaining the innate immune system on continuous alert, proto-neu transgenic female mice, which develop spontaneous mammary tumors, were systemically treated with CpG-ODNs at 10-day intervals. Tumor incidence and number of tumors/mouse were significantly lower in treated mice compared with the control group. Moreover, CpG-ODN systemic treatment significantly reduced lung metastases induced by intravenous inoculation of N202.1A cells derived from a spontaneous mammary carcinoma. Growth of established tumors was modestly inhibited after CpG-ODN systemic treatment but strongly on peritumoral application. Our data indicate that systemic repeated injection of CpG-ODN to maintain the innate immune system on continuous alert prevents the onset of genetically determined tumors and confers tumor protection when the tumor load is low.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12409317     DOI: 10.1096/fj.02-0383com

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  1 in total

1.  Intratumoral delivery of CpG-conjugated anti-MUC1 antibody enhances NK cell anti-tumor activity.

Authors:  Jorge Schettini; Amritha Kidiyoor; Dahlia M Besmer; Teresa L Tinder; Lopamudra Das Roy; Joseph Lustgarten; Sandra J Gendler; Pinku Mukherjee
Journal:  Cancer Immunol Immunother       Date:  2012-04-28       Impact factor: 6.968

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.